Logo of Blueprint Medicines

John Vassiliadis Email Address

abcdefghij@blueprintmedicines.com

Need many emails like this?Find your leads with our LinkedIn Email Finder.If you already have names, use our Email Finder by Name (available in Bulk or via API too).
Job Title

Senior Scientist

Company
Blueprint Medicines

Blueprint Medicines engages in the discovery and development of highly selective kinase inhibitors for genomically defined cancer subsets.

Bio

• Credentialed pathways/targets responsible for kidney injury/inflammation/fibrosis in acquired and inherited kidney diseases using RNA technologies integrated with genomic approach. • Established and managed collaborations with internal/external research teams to define therapeutic strategies for rare inherited genetic disorders leading to kidney injury. • Developed cell-based assays to support lead validation and optimization; developed in-vitro and ex-vivo models to screen tool compounds against fibrotic/inflammatory response and cellular injury. • Prepared study protocols and generated proof-of-concept data in established and novel in-vivo models to assess preclinical efficacy of lead candidates in preventing kidney fibrosis in chronic kidney disease. • Employed immunoassays (SDS-PAGE, ELISA, luminex), molecular/cellular assay (QRT-PCR, TLDA, RNAi, and cell proliferation/differentiation/cytotoxicity), exosome, and Flow Cytometry • Analyzed RNA data to identify pharmacodynamic biomarkers associated with mechanism of action to support clinical development of drug candidates for metabolic and kidney diseases. • Supervised research associates including hiring, training, and performance reviews. Explored cellular stress/oxidative stress/mitochondrial dysfunction in kidney cell damage and apoptosis; developed cellular assays to evaluate biological targets responsible for damage and apoptosis. • Used RNAi-based gene silencing, in vivo siRNA Delivery, and genetic and developed novel mouse models to explore the role of kidney disease, fibrosis and metabolic diseases. • Identified biological targets and explored therapeutic implications in preclinical mouse models of diabetes and focal segmental glomerulosclerosis to improve renal function and inflammation. • Developed fluorescence-based cellular and imaging assays to measure calcium channel activity and cellular stress. • Supervised students and laboratory technicians.

Last University
Went to University of the Witwatersrand
Location
Based in Massachusetts, United States.

Other people working at Blueprint Medicines:

L. Fiorenza*********@blueprintmedicines.com
Riadh LobbardiSenior Scientist I, Translational Medicines
Tracey MccainExecutive Vice President and Chief Legal Officer
Michael SiracusaAssociate Director, Corporate Development
Chris VarmaCo-Founder, Chairman and Chief Executive Officer
J. Sweig******@blueprintmedicines.com
Philina LeeChief Commercial Officer
T. Mallari********@blueprintmedicines.com
C. ParkerArea Business Manager
Vo*******@blueprintmedicines.com
Kate HavilandChief Executive Officer
Jennifer ShevlinSenior Director, Human Resources Business Partner
Debbie BumpusVice President, Human Resources
Tat Chu****@blueprintmedicines.com
Helen HoChief Business Officer

How does this work?

Anymail finder is trusted by tens of thousands of companies to provide accurate contact information to their Sales and Business Development teams.

If you’re looking to find the email of John Vassiliadis at Blueprint Medicines then you’ve come to the right place.

Wondering if it's john@blueprintmedicines.com, john.vassiliadis@blueprintmedicines.com, vassiliadis@blueprintmedicines.com, or jvassiliadis@blueprintmedicines.com? We have the answers for you.

Looking for somebody else’s email?

Find other Emails now